RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CK Life Sciences Intl (Holdings) Stock

CK Life Sciences Intl (Holdings) Revenue 2024

CK Life Sciences Intl (Holdings) Revenue

5.32 B HKD

Ticker

775.HK

ISIN

KYG2176J1058

WKN

662762

In 2024, CK Life Sciences Intl (Holdings)'s sales reached 5.32 B HKD, a 0.89% difference from the 5.28 B HKD sales recorded in the previous year.

The CK Life Sciences Intl (Holdings) Revenue history

YEARREVENUE (undefined HKD)GROSS MARGIN (%)
20235.3230,76
20225.2830,82
20215.430,17
20204.9428,47
20194.9732,35
20185.2333,14
20174.6932,90
20164.8734,15
20154.9235,41
20144.9535,13
20134.9735,04
20124.5534,17
20113.5133,61
20102.6930,51
20092.6831,35
20082.9930,34
20072.0935,19
20062.237,65
20050.6944,33
20040.3359,19

CK Life Sciences Intl (Holdings) Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into CK Life Sciences Intl (Holdings), a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CK Life Sciences Intl (Holdings) from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CK Life Sciences Intl (Holdings)’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CK Life Sciences Intl (Holdings). Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CK Life Sciences Intl (Holdings)’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CK Life Sciences Intl (Holdings)’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CK Life Sciences Intl (Holdings)’s growth potential.

CK Life Sciences Intl (Holdings) Revenue, EBIT and net profit per share

DateCK Life Sciences Intl (Holdings) RevenueCK Life Sciences Intl (Holdings) EBITCK Life Sciences Intl (Holdings) Net Income
20235.32 B HKD246.76 M HKD17.25 M HKD
20225.28 B HKD267.71 M HKD131.96 M HKD
20215.4 B HKD265.39 M HKD162.8 M HKD
20204.94 B HKD87.44 M HKD125.23 M HKD
20194.97 B HKD333.2 M HKD181.74 M HKD
20185.23 B HKD406.76 M HKD263 M HKD
20174.69 B HKD176.06 M HKD258.4 M HKD
20164.87 B HKD359.52 M HKD252.96 M HKD
20154.92 B HKD307.76 M HKD218.86 M HKD
20144.95 B HKD351.89 M HKD263.56 M HKD
20134.97 B HKD328.8 M HKD229 M HKD
20124.55 B HKD400 M HKD176.3 M HKD
20113.51 B HKD274.4 M HKD125.8 M HKD
20102.69 B HKD-5.7 M HKD208.6 M HKD
20092.68 B HKD-32.8 M HKD187.1 M HKD
20082.99 B HKD38.6 M HKD-351.8 M HKD
20072.09 B HKD29.6 M HKD117 M HKD
20062.2 B HKD114.5 M HKD102 M HKD
2005694.4 M HKD-16.9 M HKD12.2 M HKD
2004329.6 M HKD-25.8 M HKD1.9 M HKD

CK Life Sciences Intl (Holdings) stock margins

The CK Life Sciences Intl (Holdings) margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CK Life Sciences Intl (Holdings). The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CK Life Sciences Intl (Holdings).

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CK Life Sciences Intl (Holdings)'s sales revenue. A higher gross margin percentage indicates that the CK Life Sciences Intl (Holdings) retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CK Life Sciences Intl (Holdings)'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CK Life Sciences Intl (Holdings)'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the CK Life Sciences Intl (Holdings)'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CK Life Sciences Intl (Holdings). Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CK Life Sciences Intl (Holdings)'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CK Life Sciences Intl (Holdings) Margin History

CK Life Sciences Intl (Holdings) Gross marginCK Life Sciences Intl (Holdings) Profit marginCK Life Sciences Intl (Holdings) EBIT marginCK Life Sciences Intl (Holdings) Profit margin
202330.76 %4.64 %0.32 %
202230.82 %5.07 %2.5 %
202130.17 %4.91 %3.01 %
202028.47 %1.77 %2.53 %
201932.35 %6.71 %3.66 %
201833.14 %7.77 %5.03 %
201732.9 %3.75 %5.51 %
201634.15 %7.38 %5.2 %
201535.41 %6.26 %4.45 %
201435.13 %7.1 %5.32 %
201335.04 %6.61 %4.61 %
201234.17 %8.8 %3.88 %
201133.61 %7.81 %3.58 %
201030.51 %-0.21 %7.74 %
200931.35 %-1.22 %6.98 %
200830.34 %1.29 %-11.76 %
200735.19 %1.42 %5.59 %
200637.65 %5.21 %4.64 %
200544.33 %-2.43 %1.76 %
200459.19 %-7.83 %0.58 %

CK Life Sciences Intl (Holdings) Aktienanalyse

What does CK Life Sciences Intl (Holdings) do?

CK Life Sciences International (Holdings) Inc (CKLS) is a leading company in the field of life sciences and biotechnology, founded in Hong Kong in 1994. It is a subsidiary of CK Hutchison Holdings, one of the largest conglomerates in Asia. CKLS operates in the business sectors of agricultural sciences, health sciences, and investment. The company has international offices in Australia, the USA, Canada, China, and Europe. The agricultural sciences division of CKLS focuses on research and development of plant-based technologies, including plant breeding, agricultural production, and biological pest control. CKLS specifically engages in the development of breeding techniques that enhance the speed, efficiency, and precision of plant breeding. The goal is to increase agricultural production and reduce the ecological footprint. CKLS also has its own brand of biological plant protection products called ABOUND, which provides protection against pests and diseases. The health sciences division of CKLS encompasses research and development of pharmaceuticals and dietary supplements. The company specializes in the development of dietary supplements made from natural ingredients that are intended to promote health and well-being. An example is the probiotic BioGaia, which is used to support digestive health and treat diarrhea. CKLS also engages in the research of herbal medicine and traditional Chinese medicine. The company has launched its own product line of traditional Chinese medicine, developed based on the millennia-old healing methods of Chinese medicine. The investment division of CKLS focuses on investing in companies and innovations that aim to improve life. For example, CKLS has invested in the US company StemCells, which specializes in the research and development of stem cell transplantation for neurological disorders. Overall, CKLS offers a wide range of products and services aimed at improving people's lives and health. Based on its research and development activities in the biotech industry, the company is working to solidify its leading role in the field of life sciences and biotechnology. In summary, CKLS is a leading company in the field of life sciences and biotechnology, operating in the sectors of agricultural sciences, health sciences, and investment. The company offers a wide range of products and services aimed at improving people's lives and health. CK Life Sciences Intl (Holdings) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding CK Life Sciences Intl (Holdings)'s Sales Figures

The sales figures of CK Life Sciences Intl (Holdings) originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing CK Life Sciences Intl (Holdings)’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize CK Life Sciences Intl (Holdings)'s sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in CK Life Sciences Intl (Holdings)’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about CK Life Sciences Intl (Holdings) stock

How much revenue did CK Life Sciences Intl (Holdings) generate this year?

CK Life Sciences Intl (Holdings) has achieved a revenue of 5.32 B HKD this year.

How much was the turnover of the company CK Life Sciences Intl (Holdings) compared to the previous year?

The revenue of CK Life Sciences Intl (Holdings) has increased by 0.89% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of CK Life Sciences Intl (Holdings)?

The revenue of CK Life Sciences Intl (Holdings) is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of CK Life Sciences Intl (Holdings) measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of CK Life Sciences Intl (Holdings) so important for investors?

The revenue of CK Life Sciences Intl (Holdings) is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does CK Life Sciences Intl (Holdings) pay?

Over the past 12 months, CK Life Sciences Intl (Holdings) paid a dividend of 0.01 HKD . This corresponds to a dividend yield of about 1.7 %. For the coming 12 months, CK Life Sciences Intl (Holdings) is expected to pay a dividend of 0.01 HKD.

What is the dividend yield of CK Life Sciences Intl (Holdings)?

The current dividend yield of CK Life Sciences Intl (Holdings) is 1.7 %.

When does CK Life Sciences Intl (Holdings) pay dividends?

CK Life Sciences Intl (Holdings) pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of CK Life Sciences Intl (Holdings)?

CK Life Sciences Intl (Holdings) paid dividends every year for the past 13 years.

What is the dividend of CK Life Sciences Intl (Holdings)?

For the upcoming 12 months, dividends amounting to 0.01 HKD are expected. This corresponds to a dividend yield of 1.7 %.

In which sector is CK Life Sciences Intl (Holdings) located?

CK Life Sciences Intl (Holdings) is assigned to the 'Health' sector.

Wann musste ich die Aktien von CK Life Sciences Intl (Holdings) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CK Life Sciences Intl (Holdings) from 6/5/2023 amounting to 0.008 HKD, you needed to have the stock in your portfolio before the ex-date on 5/23/2023.

When did CK Life Sciences Intl (Holdings) pay the last dividend?

The last dividend was paid out on 6/5/2023.

What was the dividend of CK Life Sciences Intl (Holdings) in the year 2023?

In the year 2023, CK Life Sciences Intl (Holdings) distributed 0.01 HKD as dividends.

In which currency does CK Life Sciences Intl (Holdings) pay out the dividend?

The dividends of CK Life Sciences Intl (Holdings) are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CK Life Sciences Intl (Holdings)

Our stock analysis for CK Life Sciences Intl (Holdings) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CK Life Sciences Intl (Holdings) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.